Kamada (KMDA) EBITDA Margin (2012 - 2026)
Kamada's EBITDA Margin came in at 24.40% for the quarter ended Jun 30, 2026, up 0.23 percentage points from 24.17% a year earlier and up 0.52 percentage points from the prior quarter.
Powered by 
Analysis
Kamada (KMDA) EBITDA Margin (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kamada reported EBITDA Margin of 22.48%, down 1.08 percentage points year-over-year; for the year ended Dec 31, 2025, it was 22.80%, up 1.77 percentage points from the prior year.
- EBITDA Margin has increased in each of the last four years, with a five-year change of +4.69 percentage points (years ended Dec 2020 to Dec 2025).
- Going back by year, EBITDA Margin was 21.04% in the year ended Dec 31, 2024 (+5.05 pp), 15.98% in the year ended Dec 31, 2023 (+3.08 pp), 12.90% in the year ended Dec 31, 2022 (+8.16 pp) and 4.74% in the year ended Dec 31, 2021 (-13.37 pp).
- The five-year range for quarterly EBITDA Margin is -4.15% (the quarter ended Dec 31, 2021) to 25.91% (the quarter ended Mar 31, 2025).
- Year-over-year, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +1.61 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in the quarter ended Dec 31, 2022 (a gain of 19.62 percentage points), and the weakest in the quarter ended Sep 30, 2021 (a drop of 23.63 percentage points).
- Business Quant data shows KMDA's EBITDA Margin at 23.88% (quarter ended Mar 31, 2026), 16.46% (quarter ended Dec 31, 2025) and 24.62% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Kamada | 497.25 Mn | 206.31 Mn | 22.47 Mn | 24.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.40% |
| Mar 31, 2026 | 23.88% |
| Dec 31, 2025 | 16.46% |
| Sep 30, 2025 | 24.62% |
| Jun 30, 2025 | 24.17% |
| Mar 31, 2025 | 25.91% |
| Dec 31, 2024 | 23.53% |
| Sep 30, 2024 | 20.45% |
| Jun 30, 2024 | 20.88% |
| Mar 31, 2024 | 19.28% |
| Dec 31, 2023 | 16.43% |
| Sep 30, 2023 | 19.90% |
| Jun 30, 2023 | 15.58% |
| Mar 31, 2023 | 11.11% |
| Dec 31, 2022 | 15.47% |
| Sep 30, 2022 | 17.43% |
| Jun 30, 2022 | 3.25% |
| Mar 31, 2022 | 11.65% |
| Dec 31, 2021 | -4.15% |
| Sep 30, 2021 | 1.89% |
API Access
Kamada EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=KMDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();